BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siméon FG, Culligan WJ, Lu S, Pike VW. 11C-Labeling of Aryl Ketones as Candidate Histamine Subtype-3 Receptor PET Radioligands through Pd(0)-Mediated 11C-Carbonylative Coupling. Molecules 2017;22:E792. [PMID: 28498336 DOI: 10.3390/molecules22050792] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Deng X, Rong J, Wang L, Vasdev N, Zhang L, Josephson L, Liang SH. Chemie der Positronenemissionstomographie: Aktuelle Fortschritte bei 11 C‐, 18 F‐, 13 N‐ und 15 O‐Markierungsreaktionen. Angew Chem 2019;131:2604-31. [DOI: 10.1002/ange.201805501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
2 Thompson S, Kealey S, Sephton SM, Aigbirhio FI. Radiochemistry with Carbon‐11. In: Scott P, Kilbourn M, editors. Handbook of Radiopharmaceuticals. Wiley; 2020. pp. 143-249. [DOI: 10.1002/9781119500575.ch7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Taddei C, Pike VW. [11C]Carbon monoxide: advances in production and application to PET radiotracer development over the past 15 years. EJNMMI Radiopharm Chem 2019;4:25. [PMID: 31659516 DOI: 10.1186/s41181-019-0073-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
4 Łażewska D, Kieć-Kononowicz K. Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017). Expert Opin Ther Pat 2018;28:175-96. [PMID: 29334795 DOI: 10.1080/13543776.2018.1424135] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
5 Dahl K, Nakao R, Amini N, Moein MM, Finnema S, Malmquist J, Varnäs K, Schou M. Development of [ Carbonyl-11C]AZ13198083, a Novel Histamine Type-3 Receptor Radioligand with Favorable Kinetics. ACS Chem Neurosci 2018;9:906-11. [PMID: 29359917 DOI: 10.1021/acschemneuro.7b00493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]